SRE-ZBP activators are compounds that, through their action on diverse cellular mechanisms, can have an indirect influence on the expression and function of the SRE-ZBP protein. This class includes molecules that act on signaling pathways and gene regulatory mechanisms broadly, rather than specifically on SRE-ZBP.
For instance, forskolin raises intracellular cAMP, which through a cascade involving PKA and CREB, can alter transcription of various genes. CREB can bind to certain elements within gene promoters, which may include the promoter regions governing SRE-ZBP expression. Histone deacetylase inhibitors like Trichostatin A and Sodium valproate can relax chromatin structure, making the genomic DNA more accessible to transcription machinery, thus potentially enhancing SRE-ZBP transcription. Compounds such as PMA mimic diacylglycerol, activating PKC and modulating transcription factor activity that can increase SRE-ZBP levels. Other compounds in this class function through various signaling cascades, with some like LY294002 and SB431542 acting through feedback inhibition-a process where inhibiting a pathway can result in the upregulation of certain genes due to the cell's attempt to restore homeostasis.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that, paradoxically, can stabilize certain transcription factors through feedback loops, potentially increasing SRE-ZBP expression. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
An inhibitor of the TGF-β receptor that might upregulate SRE-ZBP expression through counter-regulatory mechanisms in the TGF-β signaling pathway. | ||||||